Company intelligence

BEAT

HeartBeam, Inc. · NASDAQ · Healthcare

Price$0.48-4.29% · −$0.02

Market cap26.72MEquity value

P / E-0.9Trailing ratio

Volume0Latest session

Market data

BEAT price chart

TradingView

Related signals

1 min delayed

Browse public BEAT signals with their source context and measured market impact. Open any signal for its permanent analysis page.

BEATMar 10, 2026-17.27% since signal

HeartBeam and Mount Sinai Collaborate on AI-Enabled ECG Innovations

HeartBeam is collaborating with Mount Sinai to develop AI-driven ECG algorithms, enhancing remote patient assessments. This partnership is expected to support advancements in personalized cardiac monitoring, which could significantly boost HeartBeam's market position and sales. The recent stock price increase of 6.08% signals positive market sentiment on this collaboration's potential.

View signal analysis

BEATDec 10, 2025+71.38% since signal

Why Is Micro Cap HeartBeam Stock Surging On Wednesday?

HeartBeam's stock saw a dramatic increase of 75.73% after FDA clearance. FDA granted 510(k) clearance for HeartBeam’s 12-lead ECG synthesis software. Clearance allows patients to obtain at-home ECG readings with cardiologist review. Plans for 2026 launch include targeted rollout to cardiology practices. Future developments include heart attack detection and AI-driven health tools.

View signal analysis

Research